Discover 2,272 paid clinical trials in Berkeley, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,272
Evaluation of the Optimal Transition Program
for
ESRD, Hemodialysis
Location: Oakland CA, Sacramento CA, Memphis TN
Sponsor: Satellite Healthcare
Sex: All
Age: 18+
Code: NCT04263233
Recruiting
US-guided SAPB for Rib Fractures in the ED
for
Rib Fractures, Rib Fracture Multiple
Location: Oakland CA
Sponsor: Andrew A Herring
Sex: All
Age: 18+
Code: NCT03619785
Recruiting
EMS-Initiated Buprenorphine
for
Opioid Use Disorder
Location: Oakland CA, Minneapolis MN, Camden NJ
Sponsor: Yale University
Sex: All
Age: 0+
Code: NCT07475728
Recruiting
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Oakland CA, Los Angeles CA, Long Beach CA,
Sponsor: SANUWAVE, Inc.
Sex: All
Age: 22+
Code: NCT01824407
Phase3, Recruiting
Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
for
Pain
Location: Oakland CA
Sponsor: Alameda Health System
Sex: All
Age: 18+
Code: NCT03256487
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment
for
Sleep Disturbance
Location: Alameda CA
Sponsor: IC-IT Sciences Inc.
Sex: All
Age: 30 - 65
Code: NCT03205631
Recruiting
Bupivacaine Injection of Eye Muscles to Treat Strabismus
for
Strabismus, Esotropia, Exotropia, Graves Disease,
Location: San Francisco CA
Sponsor: Smith-Kettlewell Eye Research Institute
Sex: All
Age: 8 - 70+
Code: NCT01616108
Phase2, Phase3, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Lafayette CA, Mather CA, Glendale CA, Los Angeles CA,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase2, Recruiting
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
for
Healthy Aging, Healthy, Healthy Diet
Location: San Francisco CA
Sponsor: Amazentis SA
Sex: All
Age: 18 - 70+
Code: NCT04985630
Recruiting
Behavioral and Physiological Effects of Visual Training
for
Healthy
Location: San Francisco Bay Area CA
Sponsor: Posit Science Corporation
Sex: All
Age: 60+
Code: NCT00526942
Phase1, Phase2, Recruiting
Discovering Factors in the Clinical Study Journey of Patients With OCD
for
OCD, Obsessive-Compulsive Disorder
Location: San Francisco CA
Sponsor: Power Life Sciences Inc.
Sex: All
Age: 18+
Code: NCT05881356
Recruiting
A Multicenter Cancer Biospecimen Collection Study
for
Cancer of Head and Neck, Lung Cancer, Nonsmall Cell,
Location: San Francisco CA
Sponsor: Cofactor Genomics, Inc.
Sex: All
Age: 18+
Code: NCT04510129
Recruiting
Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
for
PARKINSON DISEASE (Disorder), Parkinson s Disease
Location: San Francisco CA
Sponsor: San Francisco Neurology and Sleep Center
Sex: All
Age: 50 - 70+
Code: NCT07554833
Recruiting
Effects of Accelerated rTMS on Cognitive Function
for
Cognitive Decline, Cognitive Impairment
Location: San Francisco CA
Sponsor: San Francisco Neurology and Sleep Center
Sex: All
Age: 50 - 70+
Code: NCT07547319
Recruiting
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
for
Gastrointestinal Stromal Neoplasms
Location: San Francisco CA, Seattle WA, Omaha NE, Knoxville TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07585266
Phase3, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: San Francisco CA, Santa Monica CA, Los Angeles CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase3, Recruiting
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387